1ADAMS LA,ANGULO P.Treatmnet of non-alcoholic fatty liver disease[J].Postgrad Med J,2006,82:315.
2HUNT KJ,RESENDEZ RG,WILLIAMS K,et al.National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio heart study[J].Circulation,2004,110:1251.
3MALIK S,WONG ND,FRANKLIN SS,et al.Impact of the metabolic syndrome on mortality from coronary heart disease,cardiovascular disease,and all causes in United States adults[J].Circulation,2004,110:1245.
4BRAY GA,NIELSEN SJ,POPKIN BM.Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity[J].Am J Clin Nutr,2004,79:537.
5ARCHER WR,LAMARCHE B,DERIAZ O,et al.Variations in body composition and plasma lipids in response to a high-carbohydrate diet[J].Obes Res,2003,11:978.
6HATZITOLIOS A,SAVOPOULOS C,LAZARAKI G,et al.Efficacy of omega-3 fatty acids,atorvastatin and orlistat in non-alcoholic fatty liver disease with dyslipidemia[J].Indian J gastroenterol,2004,23:131.
7ROLLINS G.Moderate exercise reduces the risk of heart disease and death in men with type 2 diabetes[J].Rep Med Guidelines Outcomes Res,2003,14:10.
9SABUNCU T,NAZLIGUL Y,KARAOGLANOGLU M,et al.The effects of sibutramine and orlistat on the ultrasonographic findings,insulin resistance and liver enzyme levels in obese patients with nonalcoholic steatohepatitis[J].Rom J Gastroenterol,2003,12:189.
10HARRISON SA,FINCKE C,HELINSKI D,et al.A pilot study of orlistat treatment in obese,non-alcoholic steatohepatitis patients[J].Aliment Pharmacol Ther,2004,20:623.
